Cancer Family
Neck Neoplasm
CI-CAN-00000283Explore in graph →
Non-malignant634 active trials11 approved drugs67 evidence items
- NCIt
- C3260
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000283Explore in graph →
Clinical trials
2,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01249443 | Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection | terminated | Phase 1 | 17 | AIDS Malignancy ConsortiumNETWORK | 1 | Jul 29, 2020 | clinicaltrials |
| NCT04292990 | Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients | unknown | Phase 4 | 300 | Jiarong Chen, MDOTHER | 0 | Jul 29, 2020 | clinicaltrials |
| NCT02174679 |
| 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access) |
| no longer available |
| — |
| — |
| Jonsson Comprehensive Cancer CenterOTHER |
| 1 |
| Jul 27, 2020 |
| clinicaltrials |
| NCT03294005 | Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography | completed | — | 1,949 | China Medical University HospitalOTHER | 1 | Jul 21, 2020 | clinicaltrials |
| NCT04472403 | Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT04476641 | A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors(DC-CIK) | unknown | Phase 2 | 686 | Sun Yat-sen UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT01187238 | The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma | completed | Phase 2 | 84 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT04076514 | The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma(pCND) | unknown | — | 20 | Assiut UniversityOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT04446663 | Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 50 | First People's Hospital of FoshanOTHER | 0 | Jun 25, 2020 | clinicaltrials |
| NCT04447326 | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma | unknown | Phase 2 | 106 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | Jun 25, 2020 | clinicaltrials |
| NCT04447612 | Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 118 | The University of Hong KongOTHER | 1 | Jun 25, 2020 | clinicaltrials |
| NCT02444949 | A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma | completed | Phase 2 | 75 | China Three Gorges University, Yichang, ChinaOTHER | 0 | Jun 24, 2020 | clinicaltrials |
| NCT02726503 | Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer(HOPE) | completed | Phase 2 | 39 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT00341146 | Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) | completed | — | 6,490 | National Cancer Institute (NCI)NIH | 1 | Jun 16, 2020 | clinicaltrials |
| NCT02627807 | Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma | unknown | N/A | 386 | Sun Yat-sen UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT03871387 | The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory Change | completed | N/A | 88 | Yonsei UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT00287287 | REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas | completed | Phase 2 | 25 | Kenneth AinOTHER | 1 | Jun 12, 2020 | clinicaltrials |
| NCT04303975 | The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma | unknown | — | 300 | Jiarong Chen, MDOTHER | 0 | Jun 11, 2020 | clinicaltrials |
| NCT04424485 | Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy | unknown | N/A | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04425512 | Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy | completed | N/A | 333 | Kahramanmaras Sutcu Imam UniversityOTHER | 0 | Jun 11, 2020 | clinicaltrials |
| NCT04421469 | Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC | unknown | Phase 2 | 39 | Fujian Cancer HospitalOTHER_GOV | 1 | Jun 9, 2020 | clinicaltrials |
| NCT04419324 | To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer | unknown | N/A | 40 | Chinese University of Hong KongOTHER | 0 | Jun 5, 2020 | clinicaltrials |
| NCT00393224 | Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families | terminated | — | 952 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01257100 | Environmental and Genetic Determinants of NPC | terminated | — | 3,500 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04414566 | Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 562 | West China HospitalOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04411290 | Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases | unknown | — | 200 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 2, 2020 | clinicaltrials |
| NCT03134976 | Wound Complications in Head and Neck Surgery | completed | — | 51 | University of MichiganOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT04410601 | Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT(Dysphagia-TT) | unknown | N/A | 500 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 1, 2020 | clinicaltrials |
| NCT04396912 | Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort | unknown | — | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | May 21, 2020 | clinicaltrials |
| NCT04394091 | Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma Patients | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT00181220 | Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma | withdrawn | Phase 1 | 0 | Johns Hopkins UniversityOTHER | 1 | May 18, 2020 | clinicaltrials |
| NCT00367718 | Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma | withdrawn | Phase 2 | 0 | Johns Hopkins UniversityOTHER | 2 | May 18, 2020 | clinicaltrials |
| NCT01192815 | Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck | terminated | Phase 2 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT02223052 | Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies | completed | Phase 1 | 89 | CelgeneINDUSTRY | 1 | May 12, 2020 | clinicaltrials |
| NCT04061278 | A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 3 | 246 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT02111460 | Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 126 | Sun Yat-sen UniversityOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT01440270 | Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | completed | Phase 2 | 145 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT02911155 | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists | completed | — | 229 | National Cancer Institute (NCI)NIH | 1 | May 5, 2020 | clinicaltrials |
| NCT02236936 | Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck(AGMT_HNO_PN) | terminated | Phase 3 | 8 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT03670342 | Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer | completed | — | 20 | National Cancer Centre, SingaporeOTHER | 1 | Apr 30, 2020 | clinicaltrials |
| NCT00784303 | Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology | completed | Phase 2 | 117 | Eisai Inc.INDUSTRY | 6 | Apr 22, 2020 | clinicaltrials |
| NCT04351282 | SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma | unknown | N/A | 43 | Fudan UniversityOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT00158678 | IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC | completed | Phase 3 | 310 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Apr 15, 2020 | clinicaltrials |
| NCT00342407 | The Incidence of Breast and Other Cancers Among Female Flight Attendants | completed | — | 6,093 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2020 | clinicaltrials |
| NCT01344356 | Stereotactic Body Radiotherapy for Head and Neck Tumors | completed | Phase 4 | 19 | Mercy ResearchOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT04336696 | Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? | unknown | N/A | 199 | Bassem Mohamed SiedaOTHER_GOV | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03689556 | Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy | unknown | — | 40 | Shanghai Proton and Heavy Ion CenterOTHER | 0 | Apr 6, 2020 | clinicaltrials |
| NCT03132727 | Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer(Larynx MRI) | completed | — | 73 | Hospices Civils de LyonOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT03969108 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Mar 27, 2020 | clinicaltrials |
| NCT03211117 | Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer | completed | Phase 2 | 3 | Mayo ClinicOTHER | 1 | Mar 25, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Jul 29, 2020source: clinicaltrials